SEC Form 4 · accession 0001140361-16-058497
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew H Galligan
Officer — Chief Financial Officer
Period of report
Mar 17, 2016
Accepted (ET)
Mar 21, 2016 · 12:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 17, 2016 | M | 25,500 | $1.44 | A | 30,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.44 | Mar 17, 2016 | M | 25,500 | D | — | May 17, 2020 | Common Stock | 25,500 | 37,404 | D |
Explanation of responses
- F1100% of the shares subject to the option are fully vested and exercisable.